Holen Sie sich die Stockscreener-App
6.97
2.38%
-0.17
Schlusskurs vom Vortag:
$7.14
Offen:
$7.2
24-Stunden-Volumen:
60,402
Relative Volume:
0.42
Marktkapitalisierung:
$355.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-1.5152
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
-8.05%
1M Leistung:
+19.55%
6M Leistung:
-22.47%
1J Leistung:
-7.68%
1-Tages-Spanne:
$6.75
$7.70
1-Wochen-Bereich:
$6.3192
$7.99
52-Wochen-Spanne:
$4.42
$18.40
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Vergleichen Sie ENGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
6.97 | 355.31M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
(ENGN) Proactive Strategies - Stock Traders Daily
Insider Returns Down To US$14k As enGene Holdings' Stock Dips 11% - Simply Wall St
How Much Upside is Left in enGene Holdings Inc. (ENGN)? Wall Street Analysts Think 238.77% - MSN
(ENGN) Trading Report - Stock Traders Daily
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why - MSN
enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of “Buy” by Analysts - Defense World
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
(ENGN) Technical Pivots with Risk Controls - Stock Traders Daily
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 93.4% in December - MarketBeat
Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles - MSN
HC Wainwright Forecasts enGene’s Q1 Earnings (NASDAQ:ENGN) - Defense World
What is HC Wainwright's Estimate for enGene Q1 Earnings? - MarketBeat
Engene shares initiated at Buy as promising detalimogene data positions it ahead of recent approvals - Investing.com Nigeria
enGene (NASDAQ:ENGN) Receives “Market Outperform” Rating from JMP Securities - Defense World
enGene (NASDAQ:ENGN) Now Covered by Analysts at HC Wainwright - Defense World
enGene (NASDAQ:ENGN) Receives Market Outperform Rating from JMP Securities - MarketBeat
enGene (NASDAQ:ENGN) Now Covered by HC Wainwright - MarketBeat
Franklin Resources Inc. Buys 389,918 Shares of enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat
enGene Holdings inks $100M share sale deal with Jefferies - Investing.com
EnGene : Material Agreement Form 8 K - Marketscreener.com
Form 424B5 enGene Holdings Inc. - StreetInsider.com
EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2024 - Marketscreener.com
enGene Reports Full Year 2024 Financial Results and Provides a Business Update - BioSpace
enGene Holdings Inc. (ENGN) reports earnings - Quartz
enGene (NASDAQ:ENGN) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook (NASDAQ:ENGN) - Seeking Alpha
Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks - MSN
(ENGN) Investment Analysis - Stock Traders Daily
Point72 Asset Management L.P. Has $4.38 Million Holdings in enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat
enGene’s (ENGN) Market Outperform Rating Reiterated at JMP Securities - Defense World
enGene's (ENGN) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Critical Comparison: OKYO Pharma (NASDAQ:OKYO) versus enGene (NASDAQ:ENGN) - Defense World
Contrasting Immunovant (NASDAQ:IMVT) and enGene (NASDAQ:ENGN) - Defense World
Raymond James Initiates Coverage of enGene Holdings (ENGN) with Outperform Recommendation - MSN
enGene (NASDAQ:ENGN) Earns Outperform Rating from Analysts at Raymond James - MarketBeat
Recent uptick might appease enGene Holdings Inc. (NASDAQ:ENGN) institutional owners after losing 4.2% over the past year - Simply Wall St
enGene to Participate in Upcoming Investor Conferences - Vulcan Advocate
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Engene Holdings Inc-Aktie (ENGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
| Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
| Forbion Growth Opportunities F | 10% Owner |
Oct 08 '24 |
Buy |
6.60 |
800 |
5,278 |
2,470,633 |
| Cooper Ronald Harold Wilfred | Chief Executive Officer |
Sep 27 '24 |
Buy |
5.70 |
10,000 |
57,000 |
10,000 |
| Glickman Richard M | Director |
May 28 '24 |
Option Exercise |
0.89 |
120 |
107 |
24,675 |
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):